Stockreport

Novo Nordisk: Competing In A Duopoly [Seeking Alpha]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF NVO's future growth hinges on defending market share with new GLP-1 products, including oral Wegovy, higher-dose Wegovy, and an innovative pipeline. Despite a strong [Read more]